Literature DB >> 1468915

Epithelial membrane antigen and S-100 protein-labeled cells in primary and metastatic laryngeal carcinomas.

T Nakashima1, G Yano, I Hayashi, Y Katsuta.   

Abstract

Immunohistochemical studies were done on the expression of S-100 protein-labeled cells in human laryngeal carcinoma of epithelial membrane antigen (EMA) and on the population density. EMA was detected in 65 of 76 (86%) squamous cell carcinomas and was usually more extensively positive in well and moderately differentiated carcinomas. Thus, EMA can serve as a marker of malignancy in laryngeal carcinomas. The population density of S-100 protein-labeled cells was high in well-differentiated tissues. In the metastatic tumors, the number of S-100 protein-labeled cells decreased as compared to findings in the primary tumors. As a statistically significant difference in survival curve was noted between groups with low and intermediate density of S-100 protein-labeled cells, the infiltration of S-100 protein-labeled cells seems to be associated with a better prognosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1468915     DOI: 10.1002/hed.2880140604

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

1.  In vivo infiltration of mononuclear cells in squamous cell carcinoma of the head and neck correlates with the ability to expand tumour-infiltrating T cells in vitro and with the expression of MHC class I antigens on tumour cells.

Authors:  J Hald; N Rasmussen; M H Claesson
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

2.  Argyrophilic nucleolar organizer regions as a prognostic indicator of laryngeal carcinomas.

Authors:  T Nakashima; G Yano; A Masuda; T Uemura; M Morita
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

3.  S100P is associated with proliferation and migration in nasopharyngeal carcinoma.

Authors:  Yueyang Liu; Chengyu Wang; Xiaodong Shan; Jian Wu; Huanhai Liu; Haibin Liu; Jiping Zhang; Weihua Xu; Zhirong Sha; Jin He; Jingping Fan
Journal:  Oncol Lett       Date:  2017-05-17       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.